Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus

OBJECTIVE: A Multiple-Indicator Cluster Survey (MICS) was conducted at mid-decade in more than 60 developing countries to measure progress towards the year 2000 World Summit for Children goals. These goals included the protection of at least 90% of children against neonatal tetanus through the immun...

Full description

Bibliographic Details
Main Authors: Deming Michael S., Roungou Jean-Baptiste, Kristiansen Max, Heron Iver, Yango Alphonse, Guenengafo Alexis, Ndamobissi Robert
Format: Article
Language:English
Published: The World Health Organization 2002-01-01
Series:Bulletin of the World Health Organization
Subjects:
Online Access:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862002000900004
_version_ 1797288829303914496
author Deming Michael S.
Roungou Jean-Baptiste
Kristiansen Max
Heron Iver
Yango Alphonse
Guenengafo Alexis
Ndamobissi Robert
author_facet Deming Michael S.
Roungou Jean-Baptiste
Kristiansen Max
Heron Iver
Yango Alphonse
Guenengafo Alexis
Ndamobissi Robert
author_sort Deming Michael S.
collection DOAJ
description OBJECTIVE: A Multiple-Indicator Cluster Survey (MICS) was conducted at mid-decade in more than 60 developing countries to measure progress towards the year 2000 World Summit for Children goals. These goals included the protection of at least 90% of children against neonatal tetanus through the immunization of their mothers, as measured by tetanus toxoid (TT) coverage. In the Central African Republic (CAR), serological testing was added to the MICS to understand better the relationship between survey estimates of TT coverage and the prevalence of serological protection. METHODS: In the CAR MICS, mothers of children younger than one year of age gave verbal histories of the TT vaccinations they had received, using the MICS TT questionnaire. A subsample of mothers was tested for tetanus antitoxin, using a double-antigen enzyme-linked immunoadsorbent assay (ELISA). Seropositivity was defined as a titre of > or = 0.01 IU/ml, and TT coverage was defined as the proportion of mothers protected at delivery, according to their history of TT vaccinations. FINDINGS: Among the 222 mothers in the subsample, weighted TT coverage was 74.4% (95% Confidence Interval (CI); 67.0% - 81.7%) and tetanus antitoxin seroprevalence was 88.7% (95% CI; 83.2% - 94.2%). The weighted median antitoxin titre was 0.35 IU/ml. CONCLUSIONS: Tetanus toxoid coverage in the CAR was lower than the prevalence of serological protection against neonatal tetanus. If this relationship holds for other countries, TT coverage estimates from the MICS may underestimate the extent to which the year 2000 goal for protecting children against neonatal tetanus was reached. We also showed that a high level of serological protection had been achieved in a country facing major public health challenges and resource constraints.
first_indexed 2024-03-07T18:55:07Z
format Article
id doaj.art-383c2b7ced474e21b301dc103db12fcb
institution Directory Open Access Journal
issn 0042-9686
language English
last_indexed 2024-03-07T18:55:07Z
publishDate 2002-01-01
publisher The World Health Organization
record_format Article
series Bulletin of the World Health Organization
spelling doaj.art-383c2b7ced474e21b301dc103db12fcb2024-03-02T00:24:04ZengThe World Health OrganizationBulletin of the World Health Organization0042-96862002-01-01809696703Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanusDeming Michael S.Roungou Jean-BaptisteKristiansen MaxHeron IverYango AlphonseGuenengafo AlexisNdamobissi RobertOBJECTIVE: A Multiple-Indicator Cluster Survey (MICS) was conducted at mid-decade in more than 60 developing countries to measure progress towards the year 2000 World Summit for Children goals. These goals included the protection of at least 90% of children against neonatal tetanus through the immunization of their mothers, as measured by tetanus toxoid (TT) coverage. In the Central African Republic (CAR), serological testing was added to the MICS to understand better the relationship between survey estimates of TT coverage and the prevalence of serological protection. METHODS: In the CAR MICS, mothers of children younger than one year of age gave verbal histories of the TT vaccinations they had received, using the MICS TT questionnaire. A subsample of mothers was tested for tetanus antitoxin, using a double-antigen enzyme-linked immunoadsorbent assay (ELISA). Seropositivity was defined as a titre of > or = 0.01 IU/ml, and TT coverage was defined as the proportion of mothers protected at delivery, according to their history of TT vaccinations. FINDINGS: Among the 222 mothers in the subsample, weighted TT coverage was 74.4% (95% Confidence Interval (CI); 67.0% - 81.7%) and tetanus antitoxin seroprevalence was 88.7% (95% CI; 83.2% - 94.2%). The weighted median antitoxin titre was 0.35 IU/ml. CONCLUSIONS: Tetanus toxoid coverage in the CAR was lower than the prevalence of serological protection against neonatal tetanus. If this relationship holds for other countries, TT coverage estimates from the MICS may underestimate the extent to which the year 2000 goal for protecting children against neonatal tetanus was reached. We also showed that a high level of serological protection had been achieved in a country facing major public health challenges and resource constraints.http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862002000900004Tetanus toxoid/administration and dosageTetanus antitoxinTetanus/prevention and controlInfant, NewbornImmunization scheduleImmunization programs/utilizationSeroepidemiologic studiesCluster analysisCentral African Republic
spellingShingle Deming Michael S.
Roungou Jean-Baptiste
Kristiansen Max
Heron Iver
Yango Alphonse
Guenengafo Alexis
Ndamobissi Robert
Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus
Bulletin of the World Health Organization
Tetanus toxoid/administration and dosage
Tetanus antitoxin
Tetanus/prevention and control
Infant, Newborn
Immunization schedule
Immunization programs/utilization
Seroepidemiologic studies
Cluster analysis
Central African Republic
title Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus
title_full Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus
title_fullStr Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus
title_full_unstemmed Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus
title_short Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus
title_sort tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus
topic Tetanus toxoid/administration and dosage
Tetanus antitoxin
Tetanus/prevention and control
Infant, Newborn
Immunization schedule
Immunization programs/utilization
Seroepidemiologic studies
Cluster analysis
Central African Republic
url http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862002000900004
work_keys_str_mv AT demingmichaels tetanustoxoidcoverageasanindicatorofserologicalprotectionagainstneonataltetanus
AT roungoujeanbaptiste tetanustoxoidcoverageasanindicatorofserologicalprotectionagainstneonataltetanus
AT kristiansenmax tetanustoxoidcoverageasanindicatorofserologicalprotectionagainstneonataltetanus
AT heroniver tetanustoxoidcoverageasanindicatorofserologicalprotectionagainstneonataltetanus
AT yangoalphonse tetanustoxoidcoverageasanindicatorofserologicalprotectionagainstneonataltetanus
AT guenengafoalexis tetanustoxoidcoverageasanindicatorofserologicalprotectionagainstneonataltetanus
AT ndamobissirobert tetanustoxoidcoverageasanindicatorofserologicalprotectionagainstneonataltetanus